News

SelectQuote FY2024: Revenue Up, Net Loss Down, Profitability Rises

SelectQuote FY2024: Revenue Up, Net Loss Down, Profitability Rises

SelectQuote, Inc. Reports Fourth Quarter Fiscal Year 2024 Results

Financial Highlights for Q4 FY2024

SelectQuote, Inc. (NYSE: SLQT) has shared its financial results for the fourth quarter of fiscal year 2024. The company saw consolidated revenue hit $307.2 million, a marked increase from $221.8 million during the same quarter last year. Although SelectQuote experienced a net loss of $31.0 million, this figure shows improvement compared to the $47.8 million net loss reported in Q4 FY2023. Furthermore, the company’s Adjusted EBITDA* soared to $14.4 million, bouncing back from a loss of $(5.8) million in Q4 FY2023.

Performance Overview for Fiscal Year 2024

For the fiscal year concluding on June 30, 2024, SelectQuote announced consolidated revenue of $1.3 billion, representing a substantial 30% increase from $1.0 billion in FY2023. The net loss for FY2024 totaled $34.1 million, reflecting significant improvement compared to the loss of $58.5 million recorded in FY2023. Adjusted EBITDA* rose to $117.0 million, up from $74.3 million the previous year.

Future Guidance for Fiscal Year 2025

Looking forward, SelectQuote projects fiscal year 2025 revenue to be between $1.4 billion and $1.5 billion. The anticipated net loss is estimated to range from $42 million to $6 million. Adjusted EBITDA* is expected to fall between $90 million and $120 million.

Segment Highlights for Q4 FY2024

Performance in the Senior Segment

The Senior segment achieved $114.1 million in revenue for Q4 FY2024 and posted an Adjusted EBITDA* of $27.9 million. During this quarter, the number of approved Medicare Advantage policies reached 107,272, highlighting robust performance in this essential business area.

Performance in Healthcare Services

The Healthcare Services segment brought in $145.2 million in revenue, with an Adjusted EBITDA* of $0.9 million. The company’s specialized medication management pharmacy, SelectRx, served approximately 82,000 members, which significantly contributed to the revenue growth in this segment.

Performance in Life Insurance

The Life Insurance segment recorded $42.1 million in revenue. This segment also saw an Adjusted EBITDA* of $7.2 million for Q4 FY2024, illustrating a steady contribution to the overall performance of the company.

Performance in Auto & Home Segment

The Auto & Home segment generated $7.6 million in revenue, along with an Adjusted EBITDA* of $2.5 million for Q4 FY2024. Although it remains a smaller contributor, it plays a role in the company’s total revenue.

CEO's Insights on FY2024 Results

SelectQuote’s CEO, Tim Danker, expressed his satisfaction with the outcomes for the fiscal year. He noted that both revenue and Adjusted EBITDA exceeded expectations, with revenue surpassing the midpoint of their projections by 17% and Adjusted EBITDA by 26%. Danker emphasized a commitment to profitability and cash efficiency over mere volume growth. He highlighted the strong contributions from both the Senior and Healthcare Services segments toward the company’s overall profitability.

Danker also revealed that SelectQuote has signed a non-binding letter of intent to secure about $100 million through a commissions receivable securitization. He believes this move will help optimize the company's balance sheet, lower borrowing costs, and extend the maturity of debt.

Outlook for SelectQuote

Emphasis on Healthcare Information Platform

SelectQuote is continuing to promote its healthcare information platform as a critical driver for growth. This platform connects consumers with insurance providers based on their individual healthcare needs, which creates mutual value. Such an innovative approach enhances SelectQuote’s standing within the healthcare sector.

Breakdown of Segment Results and Metrics

SelectQuote organizes its business into segments: Senior, Healthcare Services, Life, and Auto & Home. Each segment contributes to overall revenue and Adjusted EBITDA*. The company assesses performance through various metrics, including revenue, Adjusted EBITDA, submitted policies, and approved policies.

Approved policies signify those accepted by insurance carriers after submission. While not all approved policies will become currently effective, they remain a crucial metric for revenue generation.

About SelectQuote

Since its founding in 1985, SelectQuote has built a reputation as a top-tier insurance distribution company. The company’s structure enables consumers to compare policies from highly-rated insurers, ensuring they find the best options based on their specific needs. SelectQuote operates across four primary business lines: Senior, Healthcare Services, Life, and Auto & Home, each dedicated to delivering exceptional services to their respective markets.

SelectQuote Senior caters to a growing Medicare audience with a variety of plans, while SelectQuote Healthcare Services includes SelectRx, a pharmacy focused on medication management that enhances patient outcomes. SelectQuote Life and SelectQuote Auto & Home provide customized insurance solutions aimed at safeguarding families and assets.

Conclusion

SelectQuote’s results for fiscal year 2024 underscore robust growth across its core business lines. The company’s focus on profitability, combined with strategic initiatives, positions it strongly for continued growth within the insurance and healthcare sectors.

Frequently Asked Questions

What were SelectQuote's total revenues for Q4 FY2024?

SelectQuote reported consolidated revenues of $307.2 million for Q4 FY2024, up from $221.8 million a year prior.

How did SelectQuote's financial performance compare to the previous fiscal year?

The company showed significant improvement, reducing its net loss from $47.8 million in Q4 FY2023 to $31.0 million in Q4 FY2024.

What is the revenue projection for SelectQuote in fiscal year 2025?

SelectQuote expects its revenue for fiscal year 2025 to range between $1.4 billion and $1.5 billion.

What segments contributed to SelectQuote’s revenue growth in FY2024?

The Senior segment and the Healthcare Services segment played crucial roles in driving revenue growth, alongside the Life Insurance segment.

When was SelectQuote founded?

SelectQuote was founded in 1985 and has since become a leading insurance distribution company.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

Radiation Oncology Text Earns Doody's 2026 Nod

Updated Category News Views 24

Recognition in Radiation Oncology In the rapidly advancing arena of radiation oncology, staying current is no small feat. But here's a feather in the cap of one publication doing just that: Fundamentals of Radiation Oncology: Physical, Biological, and Clinical Aspects, 4th Edition. This resource has made quite the splash by snagging a spot on the 2026 Doody's Core Titles...

Continue Reading
Curis Prepares for Q3 2026 Results Amid Tough Sector Trends

Updated Category News Views 139

All Eyes on Curis as Q3 Financials Loom Just when you think you’ve seen it all in this wild biotech ride, Curis, Inc. (NASDAQ: CRIS) is prepping to roll out their third quarter financial and operating results. Circle your calendars for November 12, 2026, because the clock’s ticking down to their 4:00 p.m. ET announcement, swiftly followed by a conference call at 4:30...

Continue Reading
Home Insurance Depreciation and What it Means for You

Updated Category News Views 17

A Deep Dive into Depreciation's Impact on Home Insurance Folks, if you haven't battled the insurance beast, you're missing out on an unholy mess. Let's talk about something that's been quietly gnawing at homeowners’ wallets—depreciation in home insurance claims. Peggy Schneider, an insurance guru from Kalispell, Montana, lays it all out in HelloNation, and I'm here to...

Continue Reading
FDA Greenlights Halozyme's Cancer Treatment Breakthrough

Updated Category News Views 18

FDA's Seal of Approval: A Game Changer Well, folks, here's a twist in the story of cancer treatment with FDA giving a nod to RYBREVANT FASPRO. Johnson & Johnson's latest offering, fueled by Halozyme's groundbreaking ENHANZE technology, just snagged accelerated approval. We're not just talking any old treatment here; it's a dual-targeted therapy for head and neck cancer...

Continue Reading
Birth Registration Revolution: OSIA Interoperability Demo

Updated Category News Views 86

Bringing Birth Registration into the 21st Century Alright, let's cut through the fog. If you ask most folks about their birth certificates, you'd hear tales of tattered paper and government office runs. What if I told you this vital piece of paper could be reborn altogether? That's what the Secure Identity Alliance is up to with their OSIA Live Interoperability Demo at...

Continue Reading
TELUS Boosts Board with Strategic Executive Appointments

Updated Category News Views 47

New Faces on the TELUS Board: Shaping the Future Alright, investors, here's the scoop straight from the trenches: TELUS (TSX:TU) is shaking things up at the top. Marc Allera and Bill Thomas are stepping into the fray as the newest members of the board, effective January 1, 2027. If you're not familiar with these names, it's time to tune in because they've got the chops to...

Continue Reading
Encompass Health Faces Uncertain Future with Sea Pines

Updated Category News Views 68

Unexpected Downpour Closes Sea Pines They say when it rains, it pours. That's not just true in life, but as it happens, it's quite literal in Melbourne, Florida. A deluge of biblical proportions forced an immediate lockdown of the Sea Pines Rehabilitation Hospital. Flooded to the gills, this once stalwart institution finds its doors shuttered indefinitely. It's a...

Continue Reading
Bowling Makes a Strike at Macy's 100th Parade in NYC

Updated Category News Views 64

Rolling with Tradition: Bowling at Macy's Parade Back in the day, bowling wasn't exactly the sport making headlines. But times, they change. Here we are in the thick of things, witnessing Go Bowling getting its moment in the spotlight during the historic 100th Macy's Thanksgiving Day Parade®. It's not about raking in the dough or hitting some stocks; it’s about...

Continue Reading
PPL Reports Strong Q3; Long-Term EPS Growth Up

Updated Category News Views 29

Solid Earnings in a Challenging Market Anytime you start hearing a company like PPL boasting about their quarterly earnings, it's time to sit up straight and pay attention. The utility giant didn’t just match expectations, they beat 'em, clocking in with $0.54 per share in ongoing earnings for Q3 2026, up from $0.48 the previous year. Not a bad step forward if you ask...

Continue Reading
Tucows Shows Progress in Q3 2026 Amidst Net Loss

Updated Category News Views 140

Q3 Snapshot: Balancing Act at Tucows Man, if there's one thing you can count on from Tucows, it's that they'll shuffle the deck just when you're getting comfortable. Here in the third quarter of 2026, they've managed a decent juggling act. Their unaudited numbers show consolidated net revenue ticking up 1.4% from last year, rounding out at a cool $100 million. That's...

Continue Reading

Top 5 Most Recently Viewed Articles

Nicole Kidman's New Role as Clé de Peau Beauté Ambassador

Updated Category News Views 302

Nicole Kidman Joins Clé de Peau Beauté as Global Brand Ambassador The renowned and celebrated Hollywood actress, Nicole Kidman, has taken on a monumental role as the new Global Brand Ambassador for Clé de Peau Beauté, a brand recognized for its luxurious skincare and makeup offerings. Kidman's exceptional presence in the entertainment industry transcends mere stardom;...

Continue Reading
Future FinTech Group Unveils Innovative AI Trading Platform

Updated Category News Views 171

Future FinTech Group Launches AI-Powered Trading Platform Future FinTech Group Inc. (NASDAQ: FTFT), known for its comprehensive financial and digital technology services, has initiated an exciting endeavor with its subsidiary, FTFT International Securities & Futures Co., Ltd. ("Future Securities"). This strategic move aims to revolutionize investment analytics and trading...

Continue Reading
GardaWorld Finalizes Successful Credit Facility Enhancements

Updated Category News Views 124

GardaWorld's Strategic Credit Facility Enhancements MONTREAL / -- Garda World Security Corporation, known as GardaWorld, is making significant strides in its operational efficiency and financial management. This entrepreneurial-driven company specializes in security services and innovative risk solutions. Recently, GardaWorld has successfully completed amendments to its...

Continue Reading
Transformative Trends in eCommerce: The Future of Marketing

Updated Category News Views 361

Understanding the Future of eCommerce Marketing As we approach a pivotal moment in the eCommerce realm, it's essential to recognize the trends that are not only shaping the industry today but are also setting the stage for 2025. The digital marketplace is evolving rapidly, and organizations must adapt to thrive. Based on insights shared by leading experts, including CEO...

Continue Reading
OSE Immunotherapeutics Reveals Strategic Innovations for Growth

Updated Category News Views 238

OSE Immunotherapeutics Shapes Future with 2026-2028 Strategic Vision OSE Immunotherapeutics has unveiled an ambitious strategic plan aimed at enhancing its product offerings and maximizing shareholder value. This plan is designed for the upcoming three years and spans innovative treatments and strategic initiatives that promise to propel the company forward in the...

Continue Reading